NasdaqCM - Nasdaq Real Time Price USD

Bon Natural Life Limited (BON)

0.0638
+0.0117
+(22.46%)
At close: May 16 at 4:00:01 PM EDT
0.0542
-0.01
(-15.05%)
After hours: May 16 at 7:48:57 PM EDT
Loading Chart for BON
  • Previous Close 0.0521
  • Open 0.0827
  • Bid 0.0110 x 20000
  • Ask 0.1500 x 100
  • Day's Range 0.0549 - 0.0845
  • 52 Week Range 0.0490 - 3.3500
  • Volume 294,626,674
  • Avg. Volume 40,274,814
  • Market Cap (intraday) 5.993M
  • Beta (5Y Monthly) -0.48
  • PE Ratio (TTM) 0.02
  • EPS (TTM) 4.2500
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. Bon Natural Life Limited was founded in 2006 and is based in Xi'an, the People's Republic of China.

www.bnlus.com

97

Full Time Employees

September 30

Fiscal Year Ends

Recent News: BON

View More

Performance Overview: BON

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BON
96.40%
S&P 500 (^GSPC)
1.30%

1-Year Return

BON
97.60%
S&P 500 (^GSPC)
12.48%

3-Year Return

BON
99.88%
S&P 500 (^GSPC)
48.66%

5-Year Return

BON
99.90%
S&P 500 (^GSPC)
108.07%

Compare To: BON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BON

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    149.82M

  • Enterprise Value

    157.04M

  • Trailing P/E

    0.38

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.01

  • Price/Book (mrq)

    3.41

  • Enterprise Value/Revenue

    6.59

  • Enterprise Value/EBITDA

    68.38

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.67%

  • Return on Assets (ttm)

    2.16%

  • Return on Equity (ttm)

    0.91%

  • Revenue (ttm)

    23.84M

  • Net Income Avi to Common (ttm)

    417.68k

  • Diluted EPS (ttm)

    4.2500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    80.47k

  • Total Debt/Equity (mrq)

    17.01%

  • Levered Free Cash Flow (ttm)

    -8.58M

Research Analysis: BON

View More

Company Insights: BON

Research Reports: BON

View More

People Also Watch